The Hopkins-Oxford Psychedelics Ethics (HOPE) Working Group Consensus Statement
The first Hopkins-Oxford Psychedelic Ethics (HOPE) workshop convened to discuss ethical matters relating to psychedelics...
The first Hopkins-Oxford Psychedelic Ethics (HOPE) workshop convened to discuss ethical matters relating to psychedelics...
The following editorial can be found in the May 2024 issue of the American Journal of Bioethics. In “Revive and Refuse: ...
Psychedelic drugs like psilocybin, LSD, MDMA, and ketamine, among others, can radically alter mood, behaviour, emotions,...
by Deanne Dunbar Dolan, PhD I write today to encourage ELSI scholars to deposit their published and unpublished res...
by Wamia Siddiqui, BS and Richard R. Sharp, PhD The following blog is an editorial found from the Am...
By Daphne O. Martschenko, PhD and Jennifer L. Young, PhD June 12 was Loving Day – a celebration of the 1...
Brian M. Cummings, MD and John J. Paris, SJ, PhD In The New York Times, almost overlooked amidst multiple arti...
by Berklee Robins, MD, MA & Ashley Sweet, MD, MBE Vaccines are approved when it is clear that the benefits to the in...
This editorial appears in the September issue of the American Journal of Bioethics by David Magnus, PhD This issue featu...
by Kiarash Aramesh M.D., Ph.D. The COVID-19 pandemic has been accompanied by a surge of pseudoscientific claims, sometim...
by Jamie Webb MA, MSci ‘An experimental vaccine against the coronavirus showed encouraging results in very early testing...
by Jing Wan,Yuqiong Huang, Amaneh Abdel Hafez Aljaafreh, Dandan Dong, Yali Cong , Jun Lin, Hongxiang Chen COVID-19 is an...